Cyclacel Pharmaceuticals Inc (CYCC)
1.87
-0.07
(-3.62%)
USD |
NASDAQ |
Apr 18, 13:01
Cyclacel Pharmaceuticals Total Return Price: 1.87 for April 18, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 17, 2024 | 1.940 |
| April 16, 2024 | 1.67 |
| April 15, 2024 | 1.57 |
| April 12, 2024 | 1.76 |
| April 11, 2024 | 1.94 |
| April 10, 2024 | 2.05 |
| April 09, 2024 | 2.11 |
| April 08, 2024 | 2.11 |
| April 05, 2024 | 2.10 |
| April 04, 2024 | 2.193 |
| April 03, 2024 | 2.19 |
| April 02, 2024 | 2.12 |
| April 01, 2024 | 2.05 |
| March 28, 2024 | 2.110 |
| March 27, 2024 | 1.96 |
| March 26, 2024 | 1.92 |
| March 25, 2024 | 2.14 |
| March 22, 2024 | 2.188 |
| March 21, 2024 | 2.18 |
| March 20, 2024 | 2.250 |
| March 19, 2024 | 2.35 |
| March 18, 2024 | 2.51 |
| March 15, 2024 | 2.43 |
| March 14, 2024 | 2.496 |
| March 13, 2024 | 2.59 |
| Date | Value |
|---|---|
| March 12, 2024 | 2.481 |
| March 11, 2024 | 2.52 |
| March 08, 2024 | 2.64 |
| March 07, 2024 | 2.49 |
| March 06, 2024 | 2.37 |
| March 05, 2024 | 2.59 |
| March 04, 2024 | 2.70 |
| March 01, 2024 | 2.90 |
| February 29, 2024 | 2.56 |
| February 28, 2024 | 2.68 |
| February 27, 2024 | 2.72 |
| February 26, 2024 | 2.80 |
| February 23, 2024 | 2.65 |
| February 22, 2024 | 2.63 |
| February 21, 2024 | 2.715 |
| February 20, 2024 | 2.93 |
| February 16, 2024 | 2.969 |
| February 15, 2024 | 2.665 |
| February 14, 2024 | 2.571 |
| February 13, 2024 | 2.49 |
| February 12, 2024 | 2.460 |
| February 09, 2024 | 2.28 |
| February 08, 2024 | 2.32 |
| February 07, 2024 | 2.33 |
| February 06, 2024 | 2.51 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
1.57
Minimum
Apr 15 2024
274.50
Maximum
Jan 10 2020
67.33
Average
56.25
Median
Dec 01 2020
Total Return Price Benchmarks
| Corvus Pharmaceuticals Inc | 1.395 |
| Oragenics Inc | 1.125 |
| Relmada Therapeutics Inc | 4.60 |
| Alpine Immune Sciences Inc | 64.46 |
| MAIA Biotechnology Inc | 2.00 |